Table 2.

Initial strategies for pharmacological treatment in major depressive disorder across practice guidelines

AD: antidepressant, AAP: atypical antipsychotic agent, ECT: Electroconvulsive therapy, TAP: typical antipsychotic agent, MS: mood stabilizer, PF: psychotic features, SSRI: selective serotonin reuptake inhibitor, SNRI: serotonin-norepinephrine reuptake inhibitor, AP: antipsychotic agent, TCA: tricyclic antidepressant, Quetiapine XR: extended release formulation of quetiapine, MAOI: monoamine oxidase inhibitor, KMAP-DD: Korean Medication Algorithm Project for Depressive Disorder, APA: American Psychiatric Association, CANMAT: Canadian Network for Mood and Anxiety Treatments, NICE: National Institute for Health and Clinical Excellence, TMAP: Texas Medication Algorithm Project, WFSBP: World Federation of Societies of Biological Psychiatry